v3.26.3
Fair Value Measurements
12 Months Ended
Sep. 30, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements

NOTE E – FAIR VALUE MEASUREMENTS

As required by U.S. GAAP, Ashland uses applicable guidance for defining fair value, the initial recording and periodic remeasurement of certain assets and liabilities measured at fair value and related disclosures for instruments measured at fair value. Fair value accounting guidance establishes a fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the instrument’s fair value measurement. The three levels within the fair value hierarchy are described as follows:

Level 1 – Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2 – Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3 – Unobservable inputs for the asset or liability for which there is little, if any, market activity at the measurement date. Unobservable inputs reflect Ashland’s own assumptions about what market participants would use to price the asset or liability. The inputs are developed based on the best information available in the circumstances, which might include Ashland’s own financial data such as internally developed pricing models, discounted cash flow methodologies, as well as instruments for which the fair value determination requires significant management judgment.

For assets that are measured using quoted prices in active markets (Level 1), the total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs. Assets and liabilities that are measured using significant other observable inputs (Level 2) are primarily valued by reference to quoted prices of similar assets or liabilities in active markets, adjusted for any terms specific to that asset or liability. For all other assets and liabilities for which unobservable inputs are used (Level 3), fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models that Ashland deems reasonable.

The following table summarizes financial instruments subject to recurring fair value measurements as of September 30, 2026. For additional information on fair value hierarchy measurements of pension plan assets, see Note L.

(In millions)

 

Carrying value

 

 

Total fair value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

480

 

 

$

480

 

 

$

480

 

 

$

—

 

 

$

—

 

Restricted investments(a)(b)

 

 

304

 

 

 

304

 

 

 

304

 

 

 

—

 

 

 

—

 

Investments of captive insurance company(c)

 

 

5

 

 

 

5

 

 

 

5

 

 

 

—

 

 

 

—

 

Commodity derivatives(d)

 

 

4

 

 

 

4

 

 

 

—

 

 

 

4

 

 

 

—

 

Total assets at fair value

 

$

793

 

 

$

793

 

 

$

789

 

 

$

4

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency derivatives(e)

 

$

2

 

 

$

2

 

 

$

—

 

 

$

2

 

 

$

—

 

Commodity derivatives(e)

 

 

2

 

 

 

2

 

 

 

—

 

 

 

2

 

 

 

—

 

Total liabilities at fair value

 

$

4

 

 

$

4

 

 

$

—

 

 

$

4

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)
Includes $248 million within restricted investments and $56 million within other current assets in the Consolidated Balance Sheets.
(b)
Includes $208 million related to the Asbestos trust and $96 million related to the Environmental trust. See Note A for additional details.
(c)
Included in other noncurrent assets in the Consolidated Balance Sheets.
(d)
Included in accounts receivable, net in the Consolidated Balance Sheets.
(e)
Included in accrued expenses and other liabilities in the Consolidated Balance Sheets.

The following table summarizes financial instruments subject to recurring fair value measurements as of September 30, 2025:

(In millions)

 

Carrying value

 

 

Total fair value

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

215

 

 

$

215

 

 

$

215

 

 

$

—

 

 

$

—

 

Restricted investments(a)(b)

 

 

347

 

 

 

347

 

 

 

347

 

 

 

—

 

 

 

—

 

Investments of captive insurance company(c)

 

 

5

 

 

 

5

 

 

 

5

 

 

 

—

 

 

 

—

 

Commodity derivatives(d)

 

 

1

 

 

 

1

 

 

 

—

 

 

 

1

 

 

 

—

 

Total assets at fair value

 

$

568

 

 

$

568

 

 

$

567

 

 

$

1

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency derivatives(e)

 

$

1

 

 

$

1

 

 

$

—

 

 

$

1

 

 

$

—

 

Commodity derivatives(e)

 

 

1

 

 

 

1

 

 

 

—

 

 

 

1

 

 

 

—

 

Total liabilities at fair value

 

$

2

 

 

$

2

 

 

$

—

 

 

$

2

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a)
Includes $297 million within restricted investments and $50 million within other current assets in the Consolidated Balance Sheets.
(b)
Includes $231 million related to the Asbestos trust and $116 million related to the Environmental trust. See Note A for additional details.
(c)
Included in other noncurrent assets in the Consolidated Balance Sheets.
(d)
Included in accounts receivable, net in the Consolidated Balance Sheets.
(e)
Included in accrued expenses and other liabilities in the Consolidated Balance Sheets.

Restricted investments

As discussed in Note A, Ashland maintains certain investments in a company restricted renewable annual trusts for the purpose of paying future asbestos indemnity and defense costs and future environmental remediation and related litigation costs. The financial instruments are designated as investment securities, classified as Level 1 measurements within the fair value hierarchy.

The following table presents gross unrealized gains and losses for the restricted investments as of:

 

 

 

 

 

Gross

 

 

Gross

 

 

 

 

(In millions)

 

Adjusted Cost

 

 

Unrealized Gain

 

 

Unrealized Loss

 

 

Fair Value

 

September 30, 2026

 

 

 

 

 

 

 

 

 

 

 

 

Demand deposit

 

$

2

 

 

$

—

 

 

$

—

 

 

$

2

 

Equity mutual fund

 

 

73

 

 

 

64

 

 

 

—

 

 

 

137

 

Fixed income mutual fund

 

 

208

 

 

 

—

 

 

 

(43

)

 

 

165

 

Fair value

 

$

283

 

 

$

64

 

 

$

(43

)

 

$

304

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2025

 

 

 

 

 

 

 

 

 

 

 

 

Demand deposit

 

$

3

 

 

$

—

 

 

$

—

 

 

$

3

 

Equity mutual fund

 

 

103

 

 

 

67

 

 

 

—

 

 

 

170

 

Fixed income mutual fund

 

 

205

 

 

 

—

 

 

 

(31

)

 

 

174

 

Fair value

 

$

311

 

 

$

67

 

 

$

(31

)

 

$

347

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table presents the investment income, net gains realized, funds restricted for specific transactions, and disbursements related to restricted investments for the years ended September 30:

(In millions)

 

2026

 

 

2025

 

 

2024

 

Investment income(a)

 

$

13

 

 

$

13

 

 

$

15

 

Net gains(a)

 

 

9

 

 

 

20

 

 

 

60

 

Funds restricted for specific transactions

 

 

9

 

 

 

8

 

 

 

5

 

Disbursements

 

 

(74

)

 

 

(62

)

 

 

(79

)

 

 

 

 

 

 

 

 

 

 

(a)
Included in the net interest and other expense (income) caption within the Statements of Consolidated Comprehensive Income (Loss).

Foreign currency derivatives

Ashland conducts business in a variety of foreign currencies. Accordingly, Ashland regularly uses foreign currency derivative instruments to manage exposure on certain transactions denominated in foreign currencies to curtail potential earnings volatility effects of certain assets and liabilities, including short-term intercompany loans denominated in currencies other than Ashland’s functional currency of an entity. These derivative contracts generally require exchange of one foreign currency for another at a fixed rate at a future date and generally have maturities of less than twelve months. All contracts are valued at fair value with net changes in fair value recorded within the selling, general and administrative expense caption of the Statements of Comprehensive Income (Loss). The impacts of these contracts were largely offset by gains and losses resulting from the impact of changes in exchange rates on transactions denominated in non-functional currencies.

The following table summarizes the net gains and losses recognized within the Statements of Consolidated Comprehensive Income (Loss) for the years ended September 30:

(In millions)

 

2026

 

 

2025

 

 

2024

 

Foreign currency derivative (losses) gains

 

$

(5

)

 

$

15

 

 

$

7

 

 

 

 

 

 

 

 

 

 

 

At September 30, 2026 and 2025, Ashland had open foreign currency derivative contracts, all with durations of within one month, to buy or sell foreign currencies. The following table summarizes the fair values of the outstanding foreign currency derivatives included in accounts receivable, net and accrued expenses and other liabilities of the Consolidated Balance Sheets at September 30:

(In millions)

 

2026

 

 

2025

 

Foreign currency derivative assets(a)

 

$

—

 

 

$

—

 

Notional contract values

 

 

19

 

 

 

44

 

 

 

 

 

 

 

Foreign currency derivative liabilities

 

$

2

 

 

$

1

 

Notional contract values

 

 

241

 

 

 

128

 

 

 

 

 

 

 

 

(a)
Zero denotes less than $1 million of activity.

 

Commodity derivatives

Natural gas derivatives

To manage its exposure to the market price volatility of natural gas consumed by its U.S. plants during the manufacturing process, Ashland regularly enters into forward contracts that are designated as cash flow hedges. See Note A for more information.

Other commodity derivatives

Ashland utilizes forward contracts to manage its exposure to the market volatility of butane consumed by its U.S. plants during the manufacturing process. These derivative instruments qualify as a hedge of future cash flows, are recognized as either assets or liabilities within the Consolidated Balance Sheets and are measured at fair value. Gains and losses related to an instrument that qualifies for hedge accounting are either recognized in the Statements of Consolidated Comprehensive Income (Loss) immediately to offset the gain or loss on the hedged item, or deferred and recorded in the equity section of the Consolidated Balance Sheets as a component of accumulated other comprehensive loss and subsequently recognized in the Statements of Consolidated Comprehensive Income (Loss) when the hedged item affects net income (loss). Cash flows from derivative financial instruments designated as cash flow hedges are classified as cash flows from operating activities in the Consolidated Statements of Cash Flows for the relevant period.

At September 30, 2026 and 2025, Ashland had open forward commodity derivative contracts to buy natural gas with durations of up to 15 months and 25 months, respectively. At September 30, 2026, Ashland had open forward commodity derivative contracts to buy butane with durations of up to 18 months. The following table summarizes the net losses recognized within the cost of sales caption of the Statements of Consolidated Comprehensive Income (Loss) for the years ended September 30:

(In millions)

 

2026

 

 

2025

 

 

2024

 

Commodity derivative losses(a)

 

$

—

 

 

$

(2

)

 

$

(6

)

 

 

 

 

 

 

 

 

 

 

(a)
Zero denotes less than $1 million of activity.

The following table summarizes the fair values of the outstanding commodity derivatives included in accounts receivable, net and accrued expenses and other liabilities of the Consolidated Balance Sheets at September 30:

(In millions)

 

2026

 

 

2025

 

Commodity derivative assets

 

$

4

 

 

$

1

 

Notional contract values

 

 

15

 

 

 

6

 

 

 

 

 

 

 

 

Commodity derivative liabilities

 

$

2

 

 

$

1

 

Notional contract values

 

 

12

 

 

 

7

 

 

 

 

 

 

 

 

Other financial instruments

At September 30, 2026 and 2025, Ashland’s long-term debt (including the current portion and excluding debt issuance cost discounts) had carrying values of $1,379 million and $1,394 million, respectively, compared to a fair value of $1,331 million and $1,366 million, respectively. The fair values of long-term debt are based on quoted market prices (level 1 of the fair value hierarchy).